[Federal Register Volume 73, Number 48 (Tuesday, March 11, 2008)]
[Page 13006]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-4849]



National Institutes of Health

Office of the Director, National Institutes of Health; Office of 
Biotechnology Activity; Recombinant DNA Research; Notice of a Meeting 
of an NIH Blue Ribbon Panel

    There will be a meeting of the NIH Blue Ribbon Panel to advise on 
the Risk Assessment of the National Emerging Infectious Disease 
Laboratory at Boston University Medical Center. The meeting will be 
held on Thursday, March 13, 2008, at the National Institutes of Health, 
Building 1, Wilson Hall, 1 Center Drive, Bethesda, Maryland 20892, from 
8:30 a.m. to approximately 2 p.m.
    Discussion will include the charge to the Panel, an overview of the 
principles of environmental protection laws, and risk assessment 
    For further information concerning this meeting contact Ms. Laurie 
Lewallen, Advisory Committee Coordinator, Office of Biotechnology 
Activities, Office of the Director, National Institutes of Health, 6705 
Rockledge Drive, Room 750, Bethesda, MD 20892-7985, 301-496-9838, 
[email protected].
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed above in 
advance of the meeting. Any interested person may file written comments 
with the panel by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one form 
of identification (for example, a government-issued photo ID, driver's 
license, or passport) and to state the purpose of their visit.
    An agenda and any additional information for the meeting will be 
posted on the agency's Web site: http://www.nih.gov/about/director/acd/index.htm.
    Background information may be obtained by contacting NIH OBA by e-
mail [email protected].

    Dated: March 4, 2008.
Amy P. Patterson,
Director, Office of Biotechnology Activities.
 [FR Doc. E8-4849 Filed 3-10-08; 8:45 am]